Washington Healthcare Update - September 2022 #2 | McGuireWoods Consulting
This Week in Washington: Congress Focuses on FDA User Fee Legislation, Telehealth and Continuing Resolution; Administration Issues Executive Order on Biomanufacturing.
Stay updated with breaking news from Biopreferred Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
This Week in Washington: Congress Focuses on FDA User Fee Legislation, Telehealth and Continuing Resolution; Administration Issues Executive Order on Biomanufacturing.
/PRNewswire/ -- VGrid Energy Systems, Inc. announced today that it has earned the U.S. Department of Agriculture (USDA) Certified Biobased Product label. The...
/PRNewswire/ -- Global lignin market value is predicted to surpass USD 1.15 billion by 2028, according to a new research report by Global Market Insights Inc....
According to an item in the U.S. Department of Agriculture’s (USDA) Unified Agenda, which was published on June 21, 2022, USDA intended to publish in June 2022 a proposed rule that...
Study Predicts BioTech’s Long-Term Impact on Defense